Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - FREE CASH FLOW
Free Cash Flow KALV - KalVista Pharmaceuticals, Inc.
-89.7 M
LAST VALUE
-6.50%
2 YEAR CAGR
-19.08%
5 YEAR CAGR
-33.80%
10 YEAR CAGR